Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jurgen B Bulitta

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Antimicrobial Agents and Chemotherapy|September 14, 2011
Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic modelPhillip J Bergen, Brian T Tsuji, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2012
Front-loaded linezolid regimens result in increased killing and suppression of the accessory gene regulator system of Staphylococcus aureusBrian T Tsuji, Tanya Brown, Ridhi Parasrampuria, et al.
Antimicrobial Agents and Chemotherapy|February 12, 2014
Clinical population pharmacokinetics and toxicodynamics of linezolidLauren M Boak, Craig R Rayner, M Lindsay Grayson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 20, 2014
Quantitative determination of absorption and first-pass metabolism of apicidin, a potent histone deacetylase inhibitorBeom Soo Shin, Sun Dong Yoo, Tae Hwan Kim, et al.
Journal of Toxicology and Environmental Health. Part A|October 19, 2010
Assessment of bisphenol A exposure in Korean pregnant women by physiologically based pharmacokinetic modelingBeom Soo Shin, Sang Wook Hwang, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2013
New dosing strategies for an old antibiotic: pharmacodynamics of front-loaded regimens of colistin at simulated pharmacokinetics in patients with kidney or liver diseaseGauri G Rao, Neang S Ly, Curtis E Haas, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2012
The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic/pharmacodynamic modelZakuan Z Deris, Heidi H Yu, Kathryn Davis, et al.
International Journal of Antimicrobial Agents|April 1, 2024
Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencingSiobhonne K J Breen, Marina Harper, Carla López-Causapé, et al.
International Journal of Antimicrobial Agents|June 14, 2023
Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activityAkosua A Agyeman, Carla López-Causapé, Kate E Rogers, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Antimicrobial Agents and Chemotherapy|September 14, 2011
Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic modelPhillip J Bergen, Brian T Tsuji, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2012
Front-loaded linezolid regimens result in increased killing and suppression of the accessory gene regulator system of Staphylococcus aureusBrian T Tsuji, Tanya Brown, Ridhi Parasrampuria, et al.
Antimicrobial Agents and Chemotherapy|February 12, 2014
Clinical population pharmacokinetics and toxicodynamics of linezolidLauren M Boak, Craig R Rayner, M Lindsay Grayson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 20, 2014
Quantitative determination of absorption and first-pass metabolism of apicidin, a potent histone deacetylase inhibitorBeom Soo Shin, Sun Dong Yoo, Tae Hwan Kim, et al.
Journal of Toxicology and Environmental Health. Part A|October 19, 2010
Assessment of bisphenol A exposure in Korean pregnant women by physiologically based pharmacokinetic modelingBeom Soo Shin, Sang Wook Hwang, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2013
New dosing strategies for an old antibiotic: pharmacodynamics of front-loaded regimens of colistin at simulated pharmacokinetics in patients with kidney or liver diseaseGauri G Rao, Neang S Ly, Curtis E Haas, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2012
The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic/pharmacodynamic modelZakuan Z Deris, Heidi H Yu, Kathryn Davis, et al.
International Journal of Antimicrobial Agents|April 1, 2024
Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencingSiobhonne K J Breen, Marina Harper, Carla López-Causapé, et al.
International Journal of Antimicrobial Agents|June 14, 2023
Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activityAkosua A Agyeman, Carla López-Causapé, Kate E Rogers, et al.
Pageof 3